JPMorgan Chase & Co’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85.5K | Sell |
27,855
-11,647
| -29% | -$35.8K | ﹤0.01% | 4862 |
|
|
2025
Q1 | $76.2K | Sell |
39,502
-2,126,935
| -98% | -$4.1M | ﹤0.01% | 4861 |
|
|
2024
Q4 | $8.1M | Sell |
2,166,437
-220,915
| -9% | -$826K | ﹤0.01% | 2401 |
|
|
2024
Q3 | $11.7M | Buy |
2,387,352
+326,095
| +16% | +$1.59M | ﹤0.01% | 2067 |
|
|
2024
Q2 | $15.5M | Buy |
2,061,257
+1,216,792
| +144% | +$9.13M | ﹤0.01% | 1813 |
|
|
2024
Q1 | $21M | Buy |
+844,465
| New | +$21M | ﹤0.01% | 1652 |
|